Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
47
GRAL Quote, Financials, Valuation and Earnings
Last price:
$91.74
Seasonality move
:
104.48%
Day range:
$88.10 - $91.89
52-week range:
$16.56 - $115.76
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
22.69x
P/B ratio:
1.60x
Volume:
262.2K
Avg. volume:
1.1M
1-year change:
388.36%
Market cap:
$3.6B
Revenue:
$125.6M
EPS (TTM):
-$11.61
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GRAL
GRAIL, Inc.
|
$35.4M | -$3.27 | 10.23% | -1.26% | $105.00 |
|
FONR
FONAR Corp.
|
-- | -- | -- | -- | -- |
|
PRPH
ProPhase Labs, Inc.
|
$3.6M | -$0.15 | 3.99% | -50% | $13.80 |
|
TMO
Thermo Fisher Scientific, Inc.
|
$10.9B | $5.50 | 4.89% | 35.02% | $639.39 |
|
VCYT
Veracyte, Inc.
|
$124.9M | $0.32 | 11.04% | 511.28% | $47.50 |
|
XWEL
XWELL, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GRAL
GRAIL, Inc.
|
$91.86 | $105.00 | $3.6B | -- | $0.00 | 0% | 22.69x |
|
FONR
FONAR Corp.
|
$14.53 | -- | $91.5M | 13.14x | $0.00 | 0% | 0.88x |
|
PRPH
ProPhase Labs, Inc.
|
$0.69 | $13.80 | $3.2M | -- | $0.00 | 0% | 0.47x |
|
TMO
Thermo Fisher Scientific, Inc.
|
$579.94 | $639.39 | $217.9B | 33.51x | $0.43 | 0.3% | 5.03x |
|
VCYT
Veracyte, Inc.
|
$42.92 | $47.50 | $3.4B | 113.07x | $0.00 | 0% | 6.89x |
|
XWEL
XWELL, Inc.
|
$0.62 | -- | $3.6M | -- | $0.00 | 0% | 0.11x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GRAL
GRAIL, Inc.
|
2.55% | 4.765 | 2.74% | 7.26x |
|
FONR
FONAR Corp.
|
18.59% | 1.654 | 49.09% | 9.64x |
|
PRPH
ProPhase Labs, Inc.
|
52.83% | -0.268 | 40.4% | 0.07x |
|
TMO
Thermo Fisher Scientific, Inc.
|
41.15% | 1.043 | 19.57% | 0.96x |
|
VCYT
Veracyte, Inc.
|
3.12% | 1.341 | 1.49% | 5.74x |
|
XWEL
XWELL, Inc.
|
278.04% | 1.263 | 65.46% | 0.57x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GRAL
GRAIL, Inc.
|
-$17.3M | -$125.3M | -16.4% | -16.84% | -346.17% | -$63.6M |
|
FONR
FONAR Corp.
|
$10.4M | $3.2M | 4.68% | 5.84% | 12.26% | -$636K |
|
PRPH
ProPhase Labs, Inc.
|
-$650.5K | -$4.8M | -51.85% | -90.24% | -539.52% | -$3.5M |
|
TMO
Thermo Fisher Scientific, Inc.
|
$4.6B | $2.2B | 7.77% | 13.15% | 19.37% | $1.8B |
|
VCYT
Veracyte, Inc.
|
$89.4M | $23.1M | 2.43% | 2.52% | 17.53% | $42M |
|
XWEL
XWELL, Inc.
|
$1.3M | -$282K | -84.75% | -224.93% | -3.84% | -$3.1M |
GRAIL, Inc. vs. Competitors
-
Which has Higher Returns GRAL or FONR?
FONAR Corp. has a net margin of -245.83% compared to GRAIL, Inc.'s net margin of 10.25%. GRAIL, Inc.'s return on equity of -16.84% beat FONAR Corp.'s return on equity of 5.84%.
Company Gross Margin Earnings Per Share Invested Capital GRALGRAIL, Inc.-47.91% -$2.46 $2.3B FONRFONAR Corp.40.11% $0.34 $201.3M -
What do Analysts Say About GRAL or FONR?
GRAIL, Inc. has a consensus price target of $105.00, signalling upside risk potential of 14.3%. On the other hand FONAR Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that GRAIL, Inc. has higher upside potential than FONAR Corp., analysts believe GRAIL, Inc. is more attractive than FONAR Corp..
Company Buy Ratings Hold Ratings Sell Ratings GRALGRAIL, Inc.2 2 0 FONRFONAR Corp.0 0 0 -
Is GRAL or FONR More Risky?
GRAIL, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison FONAR Corp. has a beta of 1.000, suggesting its less volatile than the S&P 500 by 0.021000000000004%.
-
Which is a Better Dividend Stock GRAL or FONR?
GRAIL, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FONAR Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GRAIL, Inc. pays -- of its earnings as a dividend. FONAR Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRAL or FONR?
GRAIL, Inc. quarterly revenues are $36.2M, which are larger than FONAR Corp. quarterly revenues of $26M. GRAIL, Inc.'s net income of -$89M is lower than FONAR Corp.'s net income of $2.7M. Notably, GRAIL, Inc.'s price-to-earnings ratio is -- while FONAR Corp.'s PE ratio is 13.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GRAIL, Inc. is 22.69x versus 0.88x for FONAR Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRALGRAIL, Inc.22.69x -- $36.2M -$89M FONRFONAR Corp.0.88x 13.14x $26M $2.7M
-
Which has Higher Returns GRAL or PRPH?
ProPhase Labs, Inc. has a net margin of -245.83% compared to GRAIL, Inc.'s net margin of -774.52%. GRAIL, Inc.'s return on equity of -16.84% beat ProPhase Labs, Inc.'s return on equity of -90.24%.
Company Gross Margin Earnings Per Share Invested Capital GRALGRAIL, Inc.-47.91% -$2.46 $2.3B PRPHProPhase Labs, Inc.-73.67% -$1.65 $14.5M -
What do Analysts Say About GRAL or PRPH?
GRAIL, Inc. has a consensus price target of $105.00, signalling upside risk potential of 14.3%. On the other hand ProPhase Labs, Inc. has an analysts' consensus of $13.80 which suggests that it could grow by 19987.34%. Given that ProPhase Labs, Inc. has higher upside potential than GRAIL, Inc., analysts believe ProPhase Labs, Inc. is more attractive than GRAIL, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GRALGRAIL, Inc.2 2 0 PRPHProPhase Labs, Inc.0 0 0 -
Is GRAL or PRPH More Risky?
GRAIL, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison ProPhase Labs, Inc. has a beta of -0.657, suggesting its less volatile than the S&P 500 by 165.684%.
-
Which is a Better Dividend Stock GRAL or PRPH?
GRAIL, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ProPhase Labs, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GRAIL, Inc. pays -- of its earnings as a dividend. ProPhase Labs, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRAL or PRPH?
GRAIL, Inc. quarterly revenues are $36.2M, which are larger than ProPhase Labs, Inc. quarterly revenues of $883K. GRAIL, Inc.'s net income of -$89M is lower than ProPhase Labs, Inc.'s net income of -$6.8M. Notably, GRAIL, Inc.'s price-to-earnings ratio is -- while ProPhase Labs, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GRAIL, Inc. is 22.69x versus 0.47x for ProPhase Labs, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRALGRAIL, Inc.22.69x -- $36.2M -$89M PRPHProPhase Labs, Inc.0.47x -- $883K -$6.8M
-
Which has Higher Returns GRAL or TMO?
Thermo Fisher Scientific, Inc. has a net margin of -245.83% compared to GRAIL, Inc.'s net margin of 14.58%. GRAIL, Inc.'s return on equity of -16.84% beat Thermo Fisher Scientific, Inc.'s return on equity of 13.15%.
Company Gross Margin Earnings Per Share Invested Capital GRALGRAIL, Inc.-47.91% -$2.46 $2.3B TMOThermo Fisher Scientific, Inc.41.29% $4.28 $86.8B -
What do Analysts Say About GRAL or TMO?
GRAIL, Inc. has a consensus price target of $105.00, signalling upside risk potential of 14.3%. On the other hand Thermo Fisher Scientific, Inc. has an analysts' consensus of $639.39 which suggests that it could grow by 9.64%. Given that GRAIL, Inc. has higher upside potential than Thermo Fisher Scientific, Inc., analysts believe GRAIL, Inc. is more attractive than Thermo Fisher Scientific, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GRALGRAIL, Inc.2 2 0 TMOThermo Fisher Scientific, Inc.17 5 0 -
Is GRAL or TMO More Risky?
GRAIL, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Thermo Fisher Scientific, Inc. has a beta of 0.899, suggesting its less volatile than the S&P 500 by 10.144%.
-
Which is a Better Dividend Stock GRAL or TMO?
GRAIL, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Thermo Fisher Scientific, Inc. offers a yield of 0.3% to investors and pays a quarterly dividend of $0.43 per share. GRAIL, Inc. pays -- of its earnings as a dividend. Thermo Fisher Scientific, Inc. pays out 9.43% of its earnings as a dividend. Thermo Fisher Scientific, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios GRAL or TMO?
GRAIL, Inc. quarterly revenues are $36.2M, which are smaller than Thermo Fisher Scientific, Inc. quarterly revenues of $11.1B. GRAIL, Inc.'s net income of -$89M is lower than Thermo Fisher Scientific, Inc.'s net income of $1.6B. Notably, GRAIL, Inc.'s price-to-earnings ratio is -- while Thermo Fisher Scientific, Inc.'s PE ratio is 33.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GRAIL, Inc. is 22.69x versus 5.03x for Thermo Fisher Scientific, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRALGRAIL, Inc.22.69x -- $36.2M -$89M TMOThermo Fisher Scientific, Inc.5.03x 33.51x $11.1B $1.6B
-
Which has Higher Returns GRAL or VCYT?
Veracyte, Inc. has a net margin of -245.83% compared to GRAIL, Inc.'s net margin of 14.51%. GRAIL, Inc.'s return on equity of -16.84% beat Veracyte, Inc.'s return on equity of 2.52%.
Company Gross Margin Earnings Per Share Invested Capital GRALGRAIL, Inc.-47.91% -$2.46 $2.3B VCYTVeracyte, Inc.67.76% $0.24 $1.3B -
What do Analysts Say About GRAL or VCYT?
GRAIL, Inc. has a consensus price target of $105.00, signalling upside risk potential of 14.3%. On the other hand Veracyte, Inc. has an analysts' consensus of $47.50 which suggests that it could grow by 10.67%. Given that GRAIL, Inc. has higher upside potential than Veracyte, Inc., analysts believe GRAIL, Inc. is more attractive than Veracyte, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GRALGRAIL, Inc.2 2 0 VCYTVeracyte, Inc.8 2 1 -
Is GRAL or VCYT More Risky?
GRAIL, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Veracyte, Inc. has a beta of 1.829, suggesting its more volatile than the S&P 500 by 82.869%.
-
Which is a Better Dividend Stock GRAL or VCYT?
GRAIL, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veracyte, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GRAIL, Inc. pays -- of its earnings as a dividend. Veracyte, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRAL or VCYT?
GRAIL, Inc. quarterly revenues are $36.2M, which are smaller than Veracyte, Inc. quarterly revenues of $131.9M. GRAIL, Inc.'s net income of -$89M is lower than Veracyte, Inc.'s net income of $19.1M. Notably, GRAIL, Inc.'s price-to-earnings ratio is -- while Veracyte, Inc.'s PE ratio is 113.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GRAIL, Inc. is 22.69x versus 6.89x for Veracyte, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRALGRAIL, Inc.22.69x -- $36.2M -$89M VCYTVeracyte, Inc.6.89x 113.07x $131.9M $19.1M
-
Which has Higher Returns GRAL or XWEL?
XWELL, Inc. has a net margin of -245.83% compared to GRAIL, Inc.'s net margin of -2.87%. GRAIL, Inc.'s return on equity of -16.84% beat XWELL, Inc.'s return on equity of -224.93%.
Company Gross Margin Earnings Per Share Invested Capital GRALGRAIL, Inc.-47.91% -$2.46 $2.3B XWELXWELL, Inc.17.32% -$0.26 $13M -
What do Analysts Say About GRAL or XWEL?
GRAIL, Inc. has a consensus price target of $105.00, signalling upside risk potential of 14.3%. On the other hand XWELL, Inc. has an analysts' consensus of -- which suggests that it could grow by 1025.04%. Given that XWELL, Inc. has higher upside potential than GRAIL, Inc., analysts believe XWELL, Inc. is more attractive than GRAIL, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GRALGRAIL, Inc.2 2 0 XWELXWELL, Inc.0 0 0 -
Is GRAL or XWEL More Risky?
GRAIL, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison XWELL, Inc. has a beta of 1.227, suggesting its more volatile than the S&P 500 by 22.697%.
-
Which is a Better Dividend Stock GRAL or XWEL?
GRAIL, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. XWELL, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GRAIL, Inc. pays -- of its earnings as a dividend. XWELL, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRAL or XWEL?
GRAIL, Inc. quarterly revenues are $36.2M, which are larger than XWELL, Inc. quarterly revenues of $7.3M. GRAIL, Inc.'s net income of -$89M is lower than XWELL, Inc.'s net income of -$211K. Notably, GRAIL, Inc.'s price-to-earnings ratio is -- while XWELL, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GRAIL, Inc. is 22.69x versus 0.11x for XWELL, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRALGRAIL, Inc.22.69x -- $36.2M -$89M XWELXWELL, Inc.0.11x -- $7.3M -$211K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
